TY - JOUR
T1 - Association study of CAG repeats in the KCNN3 gene in Israeli patients with major psychosis
AU - Ritsner, Michael
AU - Amir, Sharon
AU - Koronyo-Hamaoui, Maya
AU - Gak, Eva
AU - Ziv, Hana
AU - Halperin, Tami
AU - Kitain, Ludmila
AU - Navon, Ruth
PY - 2003/9
Y1 - 2003/9
N2 - Objectives: Several studies reported contradictory findings regarding the association of major psychosis with CAG repeats in the KCNN3 gene. We investigated the contribution of the CAG repeat at the KCNN3 gene, localized to chromosome 1q21.3, to the genetic susceptibility for schizophrenia, schizoaffective and bipolar disorders. Methods: Analysis of the number of CAG repeats and the differences in allele length were performed for Israeli Ashkenazi Jews, non-Ashkenazi Jews, and Arabs diagnosed with major psychosis (n=181) versus matched ethnic controls (n=207). Results: We found no significant difference in the number of CAG repeats between the entire sample of patients and controls. However, an analysis of the differences of allele length revealed a significantly greater number of patients with identical allele length (43.1%) when compared with normal controls (30.4%). Furthermore, an earlier age of non-paranoid schizophrenia onset was found associated with differences in allele sizes. There were no significant differences in the number of CAG repeats and the differences in allele length when subjects were grouped according to gender, ethnic origins of their parents, family history, and diagnostic groups. Conclusions: Our results support the hypothesis that a contribution of the KCNN3 gene to genetic susceptibility to major psychosis and their phenotypic polymorphism may be related to the difference of allele length rather than to the number of CAG repeats.
AB - Objectives: Several studies reported contradictory findings regarding the association of major psychosis with CAG repeats in the KCNN3 gene. We investigated the contribution of the CAG repeat at the KCNN3 gene, localized to chromosome 1q21.3, to the genetic susceptibility for schizophrenia, schizoaffective and bipolar disorders. Methods: Analysis of the number of CAG repeats and the differences in allele length were performed for Israeli Ashkenazi Jews, non-Ashkenazi Jews, and Arabs diagnosed with major psychosis (n=181) versus matched ethnic controls (n=207). Results: We found no significant difference in the number of CAG repeats between the entire sample of patients and controls. However, an analysis of the differences of allele length revealed a significantly greater number of patients with identical allele length (43.1%) when compared with normal controls (30.4%). Furthermore, an earlier age of non-paranoid schizophrenia onset was found associated with differences in allele sizes. There were no significant differences in the number of CAG repeats and the differences in allele length when subjects were grouped according to gender, ethnic origins of their parents, family history, and diagnostic groups. Conclusions: Our results support the hypothesis that a contribution of the KCNN3 gene to genetic susceptibility to major psychosis and their phenotypic polymorphism may be related to the difference of allele length rather than to the number of CAG repeats.
KW - Age of onset
KW - CAG repeats
KW - Ethnicity
KW - KCNN3 gene
KW - Major psychoses
UR - http://www.scopus.com/inward/record.url?scp=0041331550&partnerID=8YFLogxK
U2 - 10.1097/00041444-200309000-00002
DO - 10.1097/00041444-200309000-00002
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0041331550
SN - 0955-8829
VL - 13
SP - 143
EP - 150
JO - Psychiatric Genetics
JF - Psychiatric Genetics
IS - 3
ER -